Fat-derived stem cells safe and feasible for SPMS, clinical trial

I have secondary progressive multiple sclerosis (SPMS) and am delighted with any advance in treating that form of the disease. This week, I am pleased that a clinical trial shows that fat-derived stem cells are a safe and feasible treatment for people with SPMS. The study, Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of …

Advertisement

Stem cell treatment helps people with MS, Phase 1 clinical trial

Stem cell treatment improved neurological symptoms of 75% of people with multiple sclerosis in a Phase 1 clinical trial, say researchers in the USA. Results were so encouraging that they prompted the team, at Tisch MS Research Center of New York, to start a Phase 2 trial. This is to allow them to assess further the safety …

Frankincense – a possible future treatment for MS, new research

One of the original Christmas presents may turn out to be a 21st century gift to people with multiple sclerosis. Most people, whatever their faith if any, will be familiar with the story of the Three Kings, or wise men. According to the story, they arrived in Bethlehem and gave the baby Jesus their offerings …

CCSVI treatment does NOT work for MS, says clinical trial

At last, researchers have found the truth about using angioplasty to treat CCSVI in people with multiple sclerosis. They have found it is not effective and say it is not recommended. The research team included Dr Paolo Zambini, the doctor who first proposed there was a link but now accepts that he was mistaken. CCSVI, …

Stem cell trial patients are leading a normal life

This is my column, today, in MS News Today. I thought you'd like to know about it: Stem Cell MS Patients Lead Normal Life Thanks To aHSCT Procedure People with MS who were involved in a long-term clinical trial are out and about enjoying a full and normal life with no signs of the disease. This …

Stem cell clinical trial is real, not ‘false hope’

This blog's story about the outcome of the long-term clinical trial of stem cell therapy was deleted from one Facebook group on the grounds that it did not wish to allow anything that would give its members ‘false hope’. Actually, nor do I. That is why, writing both in Multiple Sclerosis News Today and here, …

Long-term clinical trial Proves stem cell therapy that destroys immune system Does Stop MS

As regular readers of this blog will know, I also now write a column for MS News Today but, yesterday, I was asked to write a news story. You might be interested: Aggressive Stem Cell Therapy Stops MS Relapses, According to Long-term Clinical Trial JUNE 10, 2016  BY IAN FRANKS Stem cell treatment has been …

New multiple sclerosis treatment to repair myelin is at phase 2 trial stage of development

Anti-LINGO-1 (also known as BIIB033) is a new MS treatment being development by the pharmaceutical company Biogen. It is currently being tested in people with optic neuritis, relapsing remitting MS and secondary progressive MS in phase 2 clinical trials. LINGO is a protein found in nerve cells and myelin-making cells called oligodendrocytes. Blocking the activity …